Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis

@article{Fagot2001NevirapineAT,
  title={Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis},
  author={J. P. Fagot and M. Mockenhaupt and Jan-Nico Bouwes-Bavinck and Luigi Naldi and Cecile G. Viboud and Jean Claude Roujeau},
  journal={AIDS},
  year={2001},
  volume={15},
  pages={1843-1848}
}
ObjectiveTo draw attention to the many cases of Stevens–Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) related to nevirapine detected in a multinational case–control study of SJS and TEN. MethodsActively detected cases and matched hospital controls were interviewed for exposure to drugs and other risk factors. Data were analysed with case–control and case-crossover methods. ResultsBetween May 1997 and November 1999, a diagnosis of SJS or TEN was established in 246 patients. Eighteen… 
Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort
TLDR
The incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in a cohort of Canadian HIV patients who were receiving HIV and HIV-related medications was 5–7 per 3710 or approximately 1–2 per 1000 individuals in this cohort with HIV.
Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic review.
TLDR
Clinicians should be aware that amoxicillin alone or combined with clavulanic acid can cause SJS/TEN in patients of all ages.
Stevens-Johnson syndrome and toxic epidermal necrolysis.
TLDR
Management of patients with SJS/TEN requires rapid diagnosis, evaluation of the prognosis using SCORTEN, rapid identification and interruption of the culprit drug, specialized supportive care ideally in an intensive care unit, and the consideration of immunomodulatory agents such as high-dose intravenous immunoglobulin.
Stevens–Johnson Syndrome and HIV in Children in Swaziland
TLDR
SJS occurrence was rare in this population, with the majority of cases being associated with NVP, and all occurred within 32 days of medication initiation, providing a target window for intensified monitoring and anticipatory guidance.
Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
TLDR
High-dose corticosteroids were effective in SJS, whereas intra-venous immunoglobulin were useful in TEN and SJS/TEN overlap syndrome, and anti-convulsants were the most frequently implicated drugs.
Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.
TLDR
A multinational case-control study conducted in Europe between 1997 and 2001 evaluated the risk of medications to induce SCAR, finding that many cases were still related to a few "old" drugs with a known high risk, and risk was restricted to the first few weeks of drug intake.
Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study.
TLDR
The use of the TEN-specific severity-of-illness score (SCORTEN) was validated and several prognostic indicators were identified, most significant being HIV-tuberculosis co-infection, ≥40% skin involvement and severe sepsis.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?
BACKGROUND Withdrawal of the drug(s) that cause severe cutaneous adverse reactions is usually recommended without proof that it alters the course of those reactions. OBJECTIVE To determine whether
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
TLDR
Risks were increased for trimethoprim–sulfamethoxazole and other sulfonamide antibiotics, chlormezanone, quinolones, and aminopenicillins among drugs usually used for short periods.
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany.
TLDR
The incidence of SJS/TEN in AIDS patients in Germany was calculated for Germany based on the results of the Dokumentationszentrum schwerer Hautreaktionen , a registry for the severe skin reactions erythema exsudativum multiforme majus, SJS, and TEN that covers more than 90% of all SJS /TEN cases.
Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
TLDR
This study suggests that an illustrated atlas is a useful tool for standardizing the diagnosis of acute severe bullous disorders that are attributed to drugs or infectious agents.
Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids
TLDR
The incidence of rash complicating the first few weeks of treatment with NVP can be diminished by adding corticosteroids for 2 weeks to the standard recommendation, or by using a slowly escalating dose, which is proven to be pharmacokinetically safe.
Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.
TLDR
Rechallenge with TMP-SMX appears safe in HIV-infected patients with a history of non-life-threatening hypersensitivity and is most likely to be successful in patients withA low CD4+ lymphocyte count.
Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.
TLDR
As the frequency of hypersensitivity declines with disease progression, T lymphocytes could be effector cells in these reactions or their sensitivity to TMP-SMZ may decline with HIV disease progression.
...
1
2
...